PDGFRB and breast carcinoma: Our study revealed that high stromal integrin α11/PDGFRβ expression is correlated with a poorer clinical outcome in breast cancer patients and that this integrin harnesses the PDGFRβ/JNK signaling pathway to promote the invasion of cancer cells (280).